Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Portola Pharmaceuticals Introduces Antidote for the Reversal of Factor Xa Inhibitors
Portola Pharmaceuticals is the developer of Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], the first and only antidote designed for patients undergoing treatment with rivaroxaban and apixaban...
Amgen and Novartis Pharma Collaborate to Develop Novel Approach for Migraine Prevention
Aimovig™, developed through a collaboration between Amgen and Novartis Pharma AG, introduces a novel therapeutic approach for the prevention of migraines. It achieves this by blocking the calcitonin gene-related peptide receptor...
World's First Metal-based Probes for Detection of Dopamine Receptors - Developed by HKBU Researchers
A groundbreaking achievement has been made by a team of researchers from Hong Kong Baptist University, who have successfully developed the world's first metal-based probes for identifying dopamine receptors in living cells...
ChargePoint Technology launches VERIFI®- a Intelligent Monitoring Hub
<p xss=removed>ChargePoint Technology launches first-of-its-kind intelligent monitoring platform namely VERIFI which helps in tracking the most critical data of numerous valve installations. This will send alerts directly to H&S, maintenance and compliance teams to reduce unplanned maintenance downtime.</p> <p xss=removed>The VERIFI comprises an open/close handle which can be connected directly to ChargePoint valve for continuous recording of ...
First-of-its-kind Doptelet will soon be Available to Control Life-threatening Bleeding
Dova Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has granted approval for the prescription medicine Doptelet...
Roche Launches Hemlibra to Treat Haemophilia A without Factor VIII Inhibitors
<p>Roche launches Hemlibra for the treatment of people suffering from haemophilia A without factor VIII inhibitors.</p> <p>Hemlibra is a bispecific medicine which is injected under the patient’s skin in order to develop required proteins, activate the natural coagulation cascade and to restore the blood clotting process for people affecting with haemophilia A.</p> <p>This is a first-ever medicine to exhibit superior efficacy compared to fac...
Optical Sample Patent Approved for Breakthrough Cell Culture Management Technology
<p>The new breakthrough cell management technology now can be safe guarded with a patent right by all the Cell Culture Laboratories working with sensitive cell types.</p> <p>Under this protection, all the cell laboratories will be ensured for optimal sample security for gene therapy, cell therapy and regenerative medicine applications.</p> <p>Thermo Scientific Cell Locker system segregates the sensitive cells into separate protected chamber...
FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis
<p xss=removed>The US Food and Drug Administration (FDA) grants Proteostasis Therapeutics' PTI-428, a Breakthrough therapy for the treatment of cystic fibrosis patients with two copies of the F508del genetic mutation who are receiving Orkambi® as background therapy.</p> <p xss=removed>PTI-428 is an investigational CFTR amplifier in the development for treating CF in patients who are homozygous for the F508del mutation in the CFTR gene.</p>...
FDA Grants Breakthrough Therapy Designation to Fennec PEDMARK™
<p xss=removed>The US Food and Drug Administration (FDA) awarded breakthrough therapy designation to Fennec Pharmaceuticals’ PEDMARK™ (a unique formulation of sodium thiosulfate) for prevention of cisplatin-related ototoxicity in pediatric patients with standard-risk hepatoblastoma(SR-HB).</p> <p xss=removed>The Fast Track designation will facilitate development and accelerate the review of drugs to treat serious and life-threatening condition...
Novel Nano-Containers Enhance Effect of Anticancer Therapeutics
Researchers at the Center for Self-assembly and Complexity, part of the Institute for Basic Science (IBS), have developed innovative nano-containers capable of delivering anticancer drugs with precise timing and localization....
